UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057554
Receipt number R000065758
Scientific Title Study on the effectiveness of corrective underwear for pelvic organ prolapse.
Date of disclosure of the study information 2025/05/01
Last modified on 2025/10/09 07:27:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the effectiveness of corrective underwear for pelvic organ prolapse.

Acronym

Study on the effectiveness of corrective underwear for pelvic organ prolapse.

Scientific Title

Study on the effectiveness of corrective underwear for pelvic organ prolapse.

Scientific Title:Acronym

Study on the effectiveness of corrective underwear for pelvic organ prolapse.

Region

Japan


Condition

Condition

pelvic organ prolapse

Classification by specialty

Obstetrics and Gynecology Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the anatomical efficacy of corrective undergarments in patients with pelvic organ prolapse.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Degree of pelvic organ prolapse before and after wearing corrective underwears as assessed by MRI

Key secondary outcomes

Stages of pelvic organ prolapse, quality of life questionnaire score differences, and complications before and after wearing corrective underwears


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

MRI before and after wearing corrective underwear from 1-24 months

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Patients who are 18 years of age or older at the time of consent
2)Outpatients and inpatients: No questions asked
3)Gender: any gender
4)atients with pelvic organ prolapse
5)Patients who have been fully informed about their participation in this study, and who have given their consent of their own free will based on their full understanding of the study.

Key exclusion criteria

1)Patients ineligible for MRI examination
2)Other patients deemed inappropriate as research subjects by the principal investigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Hisanori
Middle name
Last name Taniguchi

Organization

Kansai Medical University Hospital

Division name

Department of Urology

Zip code

573-1191

Address

2-3-1 Shinmachi, Hirakata City, Osaka, Japan

TEL

072-804-0101

Email

taniguhi@hirakata.kmu.ac.jp


Public contact

Name of contact person

1st name Hisanori
Middle name
Last name Taniguchi

Organization

Kansai Medical University Hospital

Division name

Department of Urology

Zip code

573-1191

Address

2-3-1 Shinmachi, Hirakata City, Osaka, Japan

TEL

072-804-0101

Homepage URL


Email

taniguhi@hirakata.kmu.ac.jp


Sponsor or person

Institute

Kansai Medical University Hospital

Institute

Department

Personal name



Funding Source

Organization

Kansai Medical University Hospital

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kansai Medical University Hospital

Address

2-3-1 Shinmachi, Hirakata City, Osaka, Japan

Tel

072-804-0101

Email

taniguhi@hirakata.kmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 05 Month 01 Day

Date of IRB

2025 Year 07 Month 28 Day

Anticipated trial start date

2025 Year 05 Month 01 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 04 Month 08 Day

Last modified on

2025 Year 10 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000065758